Lymphadenectomy in gynaecologic cancer operations. Technical gimmick or advanced surgery with importance for survival?;Lymfadenektomiens rolle ved gynekologiske canceroperasjoner

Tidsskrift for den Norske Laegeforening

Volumn 121, Issue 10, 2001, Pages 1240-1245

  Salvesen, H B ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ENDOMETRIUM TUMOR; FEMALE; FEMALE GENITAL TRACT TUMOR; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MEDICAL ILLUSTRATION; METASTASIS; METHODOLOGY; OVARY TUMOR; PATHOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME; UTERINE CERVIX TUMOR; VULVA TUMOR;

CONTROLLED CLINICAL TRIALS; ENDOMETRIAL NEOPLASMS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MEDICAL ILLUSTRATION; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; VULVAR NEOPLASMS;

EID: 0035918249     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Kreftregisteret. Kreft i Norge 1996. 1. utg. Oslo: Institutt for epidemiologisk kreftforskning, 1999.
2. FIGO. FIGO stages, 1988 revision. Gynecol Oncol 1989; 35: 125-7.
3. Santin AD, Parham GP. Routine lymph node dissection in the treatment of early stage cancer: are we doing the right thing? Gynecol Oncol 1998; 68: 1-3.
4. LaPolla JP, Schlaerth JB, Gaddis O, Morrow CP. The influence of surgical staging on the evaluation and treatment of patients with cervical carcinoma. Gynecol Oncol 1986; 24: 194-206.
5. Cowles TA, Magrina JF, Masterson BJ, Capen CV. Comparison of clinical and surgical-staging in patients with endometrial carcinoma. Obstet Gynecol 1985; 66: 413-6.
6. Podratz KC, Symmonds RE, Taylor WF, Williams TJ. Carcinoma of the vulva: analysis of treatment and survival. Obstet Gynecol 1983; 61: 63-74.
7. Knapp RC, Friedman EA. Aortic lymph node metastases in early ovarian cancer. Am J Obstet Gynecol 1974; 119: 1013-7.
8. Petru E, Lahousen M, Tamussino K, Pickel H, Stranzl H, Stettner H et al. Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol 1994; 170: 656-62.
9. Piver MS, Barlow JJ, Lele SB. Incidence of subclinical metastasis in stage I and II ovarian carcinoma. Obstet Gynecol 1978; 52: 100-4.
10. Thompson JD. Extensive abdominal hysterectomy and bilateral pelvic lymphadenectomy. I: Coppleson M, red. Gynecologic oncology. New York: Churchill Livingstone, 1992: 1205-55.
11. Chuang L, Burke TW, Tornos C, Marino BD, Mitchell MF, Tortolero-Luna G et al. Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. Gynecol Oncol 1995; 58: 189-93.
12. Burghardt E, Pickel H, Lahousen M, Stettner H. Pelvic lymphadenectomy in operative treatment of ovarian cancer. Am J Obstet Gynecol 1986; 155: 315-9.
13. Makar AP, Tropé CG. Gynecologic malignancy and surgery: from quantity to quality of life. Curr Opin Obstet Gynecol 1992; 4: 419-29.
14. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma. Lancet 2000; 355: 1404-11.
15. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991; 40: 55-65.
16. Iversen T, Holter J. Radical surgery in stage I carcinoma of the corpus uteri. Br J Obstet Gynaecol 1981; 88: 1135-9.
17. Covens A, Rosen B, Gibbons A, Osborne R, Murphy J, DePetrillo A et al. Differences in the morbidity of radical hysterectomy between gynecological oncologists. Gynecol Oncol 1993; 51: 39-45.
18. Morton DL, Ollila DW. Critical review of the sentinel node hypothesis. Surgery 1999; 126: 815-9.
19. Medl M, Peters-Engl C, Schutz P, Vesely M, Sevelda P. First report of lymphatic mapping with isosulfan blue dye and sentinel node biopsy in cervical cancer. Anticancer Res 2000; 20: 1133-4.
20. Levenback C, Burke TW, Morris M, Malpica A, Lucas KR, Gershenson DM. Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol 1995; 59: 216-20.
21. Terada KY, Shimizu DM, Wong JH. Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol Oncol 2000; 76: 40-4.
22. Iversen T, Aalders JG, Christensen A, Kolstad P. Squamous cell carcinoma of the vulva: a review of 424 patients, 1956-1974. Gynecol Oncol 1980; 9: 271-9.
23. Iversen T, Aas M. Lymph drainage from the vulva. Gynecol Oncol 1983; 16: 179-89.
24. Thomas GM, Dembo AJ, Bryson SC, Osbome R, DePetrillo AD. Changing concepts in the management of vulvar cancer. Gynecol Oncol 1991; 42: 9-21.
25. Malfetano JH. Current management and treatment of squamous cell carcinoma of the vulva. Semin Surg Oncol 1990; 6: 354-8.
26. Ansink A, van der Velden J. Surgical interventions for early squamous cell carcinoma of the vulva. The Cochrane Library. www.update-software.com/CLIB/CLIBINET.EXE?S=0&Q= 967726909&U=NETDOKTOR&A=3&B= 0&E=0&R=0&F=&H=&D=1&L=1&N= 2&M=2&C=773&T=(VULVAR+and +CANCER) (1.9.2000).
27. DiSaia PJ, Creasman WT, Rich WM. An alternate approach to early cancer of the vulva. Am J Obstet Gynecol 1979; 133: 825-32.
28. Burke TW, Levenback C, Coleman RL, Morris M, Silva EG, Gershenson DM. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol 1995; 57: 215-20.
29. Stehman FB, Bundy BN, Thomas G, Varia M, Okagaki T, Roberts J et al. Groin dissection versus groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 1992; 24: 389-96.
30. Homesley HD, Bundy BN, Sedlis A, Adcock L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 1986; 68: 733-40.
31. Coppleson M. Early invasive squamous and adenocarcinoma of the cervix: (FIGO Stage la) clinical features and management. I: Coppleson M, red. Gynecologic oncology. New York: Churchill Livingstone, 1992: 631-48.
32. Newton M. Radical hysterectomy or radiotherapy for stage I cervical cancer. A prospective comparison with 5 and 10 years follow-up. Am J Obstet Gynecol 1975; 123: 535-42.
33. Perez CA, Camel HM, Kao MS, Hederman MA. Randomized study of preoperative radiation and surgery or irradiation alone in the treatment of stage IB and IIA carcinoma of the uterine cervix: final report. Gynecol Oncol 1987; 27: 129-40.
34. Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997; 350: 535-40.
35. Sundfør K, Tropé CG, Kjoørstad KE. Radical radiotherapy versus brachytherapy plus surgery in carcinoma of the cervix 2A and 2B. Long-term results from a randomized study 1968-1980. Acta Oncol 1996; 35 (suppl 8): 99-107.
36. Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol 1999; 73: 177-83.
37. Lahousen M, Haas J, Pickel H, Hackl A, Kurz C, Ogris H et al. Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy: a randomized, prospective, multicenter trial. Gynecol Oncol 1999; 73: 196-201.
38. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999; 340: 1154-61.
39. Tulzer H, Kupka S. The effectiveness of obligatory lymphadenectomy in treating carcinoma of the cervix. Int J Gynaecol Obstet 1978; 16: 197-203.
40. Downey GO, Polish RA, Adcock LL, Prem KA, Twiggs LB. Pretreatment surgical staging in cervical carcinoma: therapeutic efficacy of pelvic lymph node resection. Am J Obstet Gynecol 1989; 160: 1055-61.
41. Possover M, Krause N, Kuhne-Heid R, Schneider A. Value of laparoscopic evaluation of paraaortic and pelvic lymph nodes for treatment of cervical cancer. Am J Obstet Gynecol 1998; 178: 806-10.
42. Salvesen HB, Iversen OE, Akslen LA. Prognostic significance of angiogenesis and Ki-67, p53 and p21 expression: a population-based endometrial carcinoma study. J Clin Oncol 1999; 17: 1382-90.
43. Salvesen HB, Das S, Akslen LA. Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis. Clin Cancer Res 2000; 6: 153-9.
44. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987; 60: 2035-41.
45. Maggino T, Romagnolo C, Zola P, Sartori E, Landoni F, Gadducci A. An analysis of approaches to the treatment of endometrial cancer in Western Europe: a CTF study. Eur J Cancer 1995; 31A: 1993-7.
46. Corn BW, Dunton CJ, Carlson JA, Xie Y, Valicenti RK. National trends in the surgical staging of corpus cancer: a pattern-of- practice survey. Obstet Gynecol 1997; 90: 628-31.
47. Candiani GB, Belloni C, Maggi R, Colombo G, Frigoli A, Carinelli SG. Evaluation of different surgical approaches in the treatment of endometrial cancer at FIGO stage I. Gynecol Oncol 1990; 37: 6-8.
48. Trimble EL, Kosary C, Park RC. Lymph node sampling and survival in endometrial cancer. Gynecol Oncol 1998; 71: 340-3.
49. Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, Noojin F et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 1995; 56: 29-33.
50. ASTEC - a Study in the Treatment of Endometrial Cancer A randomised trial of lymphadenectomy and of external beam radiotherapy in the treatment of endometrial cancer, www. controlled-trials.com/frame.cfm?nextframe= web&page=links&isection=2 (1.9.2000).
51. Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 1980; 56: 419-27.
52. Lewis GCJ, Slack NH, Mortel R, Brass ID. Adjuvant progestogen therapy in the primary definitive treatment of endometrial cancer. Gynecol Oncol 1974; 2: 368-76.
53. Martin-Hirsch PL, Lilford RJ, Jarvis GJ. Adjuvant progestagen therapy for the treatment of endometrial cancer: review and meta-analyses of published randomised controlled trials. Eur J Obstet Gynecol Reprod Biol 1996; 65: 201-7.
54. Vergote I, Kjoørstad K, Abeler V, Kolstad P. A randomized trial of adjuvant progestagen in early endometrial cancer. Cancer 1989; 64: 1011-6.
55. Kristensen GB, Tropé C. Epithelial ovarian carcinoma. Lancet 1997; 349: 113-7.
56. Young RC. Initial therapy for early ovarian carcinoma. Cancer 1987; 60: 2042-9.
57. Trimbos JB, Schueler JA, van der Burg M, Hermans J, van Lent M, Heintz AP et al. Watch and wait after careful surgical treatment and staging in well-differentiated early ovarian cancer. Cancer 1991; 67: 597-602.
58. Tropé C, Paulsen T, Baekelandt M, Makar A. Kontroverser ved kirurgisk behandling av avansert ovarialcancer. Tidsskr Nor Lægeforen 2000; 120: 824-30.
59. Hacker NF. Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer. Therapeutic advance or surgical folly? Gynecol Oncol 1995; 56: 325-7.
60. Landoni F, Maggioni A, Benedetti-Panici PL, Grassi R, Zarrelli A, Bocciolone L et al. Randomized trial of lymphadenectomy vs sampling as surgical staging procedure at second look in epithelial ovarian cancer. Årsmøte i American Society of Clinical Oncology, 1998, abstract# 1390. www.asco.org/cgi-bin/prof/abstracts.pl? absno=1390& div=gync&year=98abstracts (1.9.2000).
61. Krag D, Moffat F. Nuclear medicine and the surgeon. Lancet 1999; 354: 1019-22.